艰难梭菌感染。
Clostridium difficile infection.
机构信息
Departments of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.
出版信息
Am J Med Sci. 2010 Sep;340(3):247-52. doi: 10.1097/MAJ.0b013e3181e939d8.
Abstract
Clostridium difficile is the leading cause of hospital-acquired diarrhea in Europe and North America and is a serious reemerging pathogen. Recent outbreaks have led to increasing morbidity and mortality and have been associated with a new strain (BI/NAP1/027) of C difficile that produces more toxin than historic strains. With the increasing incidence of C difficile infection, clinicians have also seen a change in the epidemiology with increased infections in previously low-risk populations. This chapter highlights the current knowledge on C difficile virulence, human disease, epidemic outbreaks and optimal treatment strategies.
摘要
艰难梭菌是欧洲和北美的主要医院获得性腹泻病原体，也是一种严重的重新出现的病原体。最近的疫情爆发导致发病率和死亡率上升，并与艰难梭菌的一种新型菌株（BI/NAP1/027）有关，该菌株产生的毒素比历史菌株多。随着艰难梭菌感染的发病率不断上升，临床医生也发现了流行情况的变化，以前低危人群的感染有所增加。本章重点介绍了艰难梭菌毒力、人类疾病、疫情爆发和最佳治疗策略的最新知识。
相似文献
1
Clostridium difficile infection.
Am J Med Sci. 2010 Sep;340(3):247-52. doi: 10.1097/MAJ.0b013e3181e939d8.
2
Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.
J Clin Microbiol. 2015 Apr;53(4):1216-26. doi: 10.1128/JCM.03058-14. Epub 2015 Feb 4.
3
Current status of Clostridium difficile infection epidemiology.
Clin Infect Dis. 2012 Aug;55 Suppl 2(Suppl 2):S65-70. doi: 10.1093/cid/cis319.
4
Clostridium difficile infection: a worldwide disease.
Gut Liver. 2014 Jan;8(1):1-6. doi: 10.5009/gnl.2014.8.1.1. Epub 2014 Jan 13.
5
The changing epidemiology of Clostridium difficile infections.
Clin Microbiol Rev. 2010 Jul;23(3):529-49. doi: 10.1128/CMR.00082-09.
6
An epidemic, toxin gene-variant strain of Clostridium difficile.
N Engl J Med. 2005 Dec 8;353(23):2433-41. doi: 10.1056/NEJMoa051590. Epub 2005 Dec 1.
7
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
J Clin Microbiol. 2011 Dec;49(12):4040-6. doi: 10.1128/JCM.05053-11. Epub 2011 Sep 28.
8
infection in the Asia-Pacific region.
Emerg Microbes Infect. 2019 Dec 24;9(1):42-52. doi: 10.1080/22221751.2019.1702480. eCollection 2020.
9
Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection.
Ann Lab Med. 2012 Sep;32(5):355-8. doi: 10.3343/alm.2012.32.5.355. Epub 2012 Aug 13.
10
Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.
Clin Microbiol Rev. 2013 Jul;26(3):604-30. doi: 10.1128/CMR.00016-13.
引用本文的文献
1
Lipidomics, Microbiota, and Intestinal Infection Outcome.
Int J Mol Sci. 2025 Aug 24;26(17):8214. doi: 10.3390/ijms26178214.
2
Can Gut Microbiota Analysis Reveal Infection? Evidence from an Italian Cohort at Disease Onset.
Microorganisms. 2024 Dec 25;13(1):16. doi: 10.3390/microorganisms13010016.
3
A Three-Year Analysis of Mortality in Clostridioides difficile Patients in a Tertiary Center.
Cureus. 2024 Nov 23;16(11):e74291. doi: 10.7759/cureus.74291. eCollection 2024 Nov.
4
MicroRNA miR-27a-5p Reduces Intestinal Inflammation Induced by Clostridioides difficile Flagella by Regulating the Nuclear Factor-κB Signaling Pathway.
J Infect Dis. 2025 Feb 4;231(1):e38-e46. doi: 10.1093/infdis/jiae396.
5
Phenylthiazoles with potent & optimum selectivity toward .
RSC Med Chem. 2024 Mar 22;15(6):1991-2001. doi: 10.1039/d4md00164h. eCollection 2024 Jun 19.
6
[Analysis of infection characteristics and risk factors in patients hospitalized for diarrhea in 3 university hospitals in a mid-south city of China].
Nan Fang Yi Ke Da Xue Xue Bao. 2024 May 20;44(5):998-1003. doi: 10.12122/j.issn.1673-4254.2024.05.23.
7
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen.
Saudi Med J. 2023 Sep;44(9):825-835. doi: 10.15537/smj.2023.44.9.20230216.
8
The Environment, Farm Animals and Foods as Sources of Infection in Humans.
Foods. 2023 Mar 4;12(5):1094. doi: 10.3390/foods12051094.
9
infection: traversing host-pathogen interactions in the gut.
Microbiology (Reading). 2023 Feb;169(2). doi: 10.1099/mic.0.001306.
10
Comparison between Symptomatic and Asymptomatic Mice after Infection Reveals Novel Inflammatory Pathways and Contributing Microbiota.
Microorganisms. 2022 Nov 30;10(12):2380. doi: 10.3390/microorganisms10122380.
本文引用的文献
1
Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
Am J Gastroenterol. 2010 Jul;105(7):1636-41. doi: 10.1038/ajg.2010.11. Epub 2010 Feb 9.
2
Treatment with monoclonal antibodies against Clostridium difficile toxins.
N Engl J Med. 2010 Jan 21;362(3):197-205. doi: 10.1056/NEJMoa0907635.
3
Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection.
Ann Pharmacother. 2010 Feb;44(2):352-9. doi: 10.1345/aph.1M351. Epub 2010 Jan 13.
4
Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
Clin Infect Dis. 2010 Jan 15;50(2):194-201. doi: 10.1086/649213.
5
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
Curr Opin Gastroenterol. 2010 Jan;26(1):17-25. doi: 10.1097/MOG.0b013e328333dc8d.
6
Clostridium difficile testing algorithms: what is practical and feasible?
Anaerobe. 2009 Dec;15(6):270-3. doi: 10.1016/j.anaerobe.2009.10.005. Epub 2009 Oct 22.
7
Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria.
PLoS Pathog. 2009 Oct;5(10):e1000626. doi: 10.1371/journal.ppat.1000626. Epub 2009 Oct 16.
8
Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.
Anaerobe. 2009 Dec;15(6):274-80. doi: 10.1016/j.anaerobe.2009.09.002. Epub 2009 Oct 13.
9
Fecal bacteriotherapy for recurrent Clostridium difficile infection.
Anaerobe. 2009 Dec;15(6):285-9. doi: 10.1016/j.anaerobe.2009.09.007. Epub 2009 Sep 22.
10
High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity.
Diagn Microbiol Infect Dis. 2010 Jan;66(1):24-8. doi: 10.1016/j.diagmicrobio.2009.08.015. Epub 2009 Sep 23.
Zotero 插件